Alan E. Fletcher

695 citations

12 papers · 432 · h-index 10

Impact in

Cellular and Molecular Neuroscience top 10%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
Organic Chemistry
- Synthesis and pharmacology of benzodiazepine derivatives

Papers in

Cellular and Molecular Neuroscience 10
- Neuropeptides and Animal Physiology 5
- Neuroscience and Neuropharmacology Research 3
- Neurotransmitter Receptor Influence on Behavior 2
Molecular Biology 9
- Receptor Mechanisms and Signaling 5
- Pharmacological Receptor Mechanisms and Effects 3
- Ion channel regulation and function 2
- Cancer therapeutics and mechanisms 2

Co-authors: George Marshall (5 shared papers)Alison J. Smith (4 shared papers)Smita S. Patel (7 shared papers)Kerry L. Chapman (5 shared papers)Jonathan D. Silk (2 shared papers)Charles Adkins (2 shared papers)Keith A. Wafford (2 shared papers)Ruth M. McKernan (2 shared papers)
Journals: Journal of Medicinal Chemistry (4 papers)Molecular Pharmacology (3 papers)Bioorganic & Medicinal Chemistry (2 papers)British Journal of Pharmacology (1 paper)Annals of the New York Academy of Sciences (1 paper)
Partner nations: United States United Kingdom

In The Last Decade

Alan E. Fletcher

12 papers receiving 412 citations

Peers

Countries citing papers authored by Alan E. Fletcher

Since Specialization

Citations

This map shows the geographic impact of Alan E. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Fletcher more than expected).

Fields of papers citing papers by Alan E. Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan E. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Fletcher. The network helps show where Alan E. Fletcher may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan E. Fletcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan E. Fletcher Line = papers co-authored together Alan E. Fletcher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric Acid_AReceptors Determined Using³⁶Cl Ion Flux Molecular Pharmacology ·Alison J. Smith, Luanda Alder, Jonathan D. Silk, Charles Adkins, Alan E. Fletcher, Tim M. Scales, Julie Kerby, George Marshall, Keith A. Wafford, Ruth M. McKernan, John Atack	2001	111
2	Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists: N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas Journal of Medicinal Chemistry ·José L. Castro, Richard G. Ball, Howard B. Broughton, Michael G. N. Russell, Denise Rathbone, Alan P. Watt, Raymond Baker, Kerry L. Chapman, Alan E. Fletcher, Smita S. Patel, Alison J. Smith, George Marshall, Wayne Ryecroft, Victor G. Matassa	1996	59
3	1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A Selective High-Affinity Antagonist for the Human Dopamine D₄Receptor with Excellent Selectivity over Ion Channels Journal of Medicinal Chemistry ·Robert W. Carling, Kevin W. Moore, Christopher R. Moyes, Elizabeth A. Jones, Katrine Bonner, Frances Emms, R. Marwood, Shil Patel, Smita S. Patel, Alan E. Fletcher, Margaret S. Beer, Bindi Sohal, Andrew Pike, Paul D. Leeson	1999	51
4	Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors British Journal of Pharmacology ·A.T. McKnight, Janet J. Maguire, N.J. Elliott, Alan E. Fletcher, Alan C. Foster, R. Tridgett, B.J. Williams, J. Longmore, L.L. Iversen	1991	48
5	High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing Group Journal of Medicinal Chemistry ·Graham A. Showell, Sylvie Bourrain, Joseph G. Neduvelil, Stephen R. Fletcher, Raymond Baker, Alan P. Watt, Alan E. Fletcher, Stephen B. Freedman, John A. Kemp	1994	47
6	Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. Molecular Pharmacology ·Sima Patel, Alesha Smith, Kerry L. Chapman, Alan E. Fletcher, J A Kemp, Garland R. Marshall, RJ Hargreaves, Wayne Ryecroft, L L Iversen, Susan D. Iversen	1994	35
7	Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility Journal of Medicinal Chemistry ·Mark G. Bock, Robert M. DiPardo, E. C. MELLIN, Randall C. Newton, Daniel F. Veber, Stephen B. Freedman, Alison J. Smith, Smita S. Patel, John A. Kemp, George Marshall, Alan E. Fletcher, Kerry L. Chapman, Paul Anderson, Roger Freidinger	1994	33
8	3-(1-Piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channels Bioorganic & Medicinal Chemistry ·Ian Collins, Michael Rowley, William B. Davey, Frances Emms, Rosemarie Marwood, Shil Patel, Smita S. Patel, Alan E. Fletcher, Ian Ragan, Paul D. Leeson, Ann L. Scott, Theodore P. Broten	1998	20
9	Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor Bioorganic & Medicinal Chemistry ·Sylvie Bourrain, Ian Collins, Joseph G. Neduvelil, Michael Rowley, Paul D. Leeson, Smita S. Patel, Shil Patel, Frances Emms, Rosemarie Marwood, Kerry L. Chapman, Alan E. Fletcher, Graham A. Showell	1998	10
10	C5-piperazinyl-1,4-benzodiazepines, water-soluble, orally bioa vailable CCKB/gastrin receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Graham A. Showell, Sylvie Bourrain, Stephen R. Fletcher, Joseph G. Neduvelil, Alan E. Fletcher, Stephen B. Freedman, Smita S. Patel, Alison J. Smith, George Marshall, M. Graham, Bindi Sohal, Victor G. Matassa	1995	9
11	A Second Generation of Non‐Peptide Cholecystokinin Receptor Antagonists and Their Possible Therapeutic Potential Annals of the New York Academy of Sciences ·Stephen B. Freedman, Smita S. Patel, Alesha Smith, Kerry L. Chapman, Alan E. Fletcher, J A Kemp, Garland R. Marshall, Richard Hargreaves, Kate Scholey, E. C. MELLIN, Robert M. DiPardo, Mark G. Bock, Roger Freidinger	1994	8
12	Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidA Receptors Determined Using 36Cl Ion Flux Molecular Pharmacology ·Alison J. Smith, Luanda Alder, Jonathan D. Silk, Charles Adkins, Alan E. Fletcher, Tim M. Scales, Julie Kerby, George Marshall, Keith A. Wafford, Ruth M. McKernan, John Atack	2001	1

About Alan E. Fletcher

Alan E. Fletcher is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Organic Chemistry, Oncology and Psychiatry and Mental health, having authored 12 papers that have together received 432 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers), Neuroscience and Neuropharmacology Research (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Ion channel regulation and function (2 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers), Cancer therapeutics and mechanisms (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (220 citations), Organic Chemistry (132 citations), Toxicology (11 citations), Molecular Biology (216 citations) and Behavioral Neuroscience (10 citations). Alan E. Fletcher has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include George Marshall, Alison J. Smith, Smita S. Patel, Kerry L. Chapman, Jonathan D. Silk, Charles Adkins, Keith A. Wafford, Ruth M. McKernan, John Atack and Julie Kerby. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Pharmacology, Bioorganic & Medicinal Chemistry, British Journal of Pharmacology and Annals of the New York Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Alan E. Fletcher

Impact in

Papers in i

In The Last Decade

Alan E. Fletcher

Peers

Countries citing papers authored by Alan E. Fletcher

Fields of papers citing papers by Alan E. Fletcher

All Works

About Alan E. Fletcher

Explore authors with similar magnitude of impact

Papers in